Authors: | Reidy-Lagunes, D.; Goodman, K.; Saltz, L. B. |
Editors: | Raghavan, D.; Blanke, C. D.; Johnson, D. H.; Moots, P. L.; Reaman, G. H.; Rose, P. G.; Sekeres, M. A. |
Article/Chapter Title: | Unusual tumors of the colon, rectum, and anus |
Abstract: | Cancers of the colon, rectum, and anus account for more than 150,000 new cases in the United States each year. The overwhelming majority (approximately 97%) of these are adenocarcinomas of the colon or rectum. Of the 3% that make up the uncommon tumors, approximately half, or 1.5 % of the total, will be anal carcinomas (squamous and cloacogenic) and one-third of the uncommon tumors (approximately 1% of the total) will be carcinoid tumors or neuroendocrine tumors. The remaining rare tumors, together comprising about 1% of all large bowel tumors, will be primary intestinal lymphomas, sarcomas, and melanomas. Treatment and prognoses of these tumors vary greatly, and will be discussed in this chapter. © 2012 by John Wiley & Sons, Inc. |
Keywords: | interferon; sarcoma; lymphoma; malignant melanoma; mtor; vegf; carcinoid tumors; anal carcinoma; somatostatin analogs; colon and rectum; paget disease |
Book Title: | Textbook of Uncommon Cancer. 4th ed |
ISBN: | 978-1-118-08373-4 |
Publisher: | John Wiley & Sons |
Publication Place: | Hoboken, NJ |
Date Published: | 2012-01-01 |
Start Page: | 453 |
End Page: | 463 |
Language: | English |
DOI: | 10.1002/9781118464557.ch32 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Book Chapter: 32 -- Export Date: 14 August 2017 -- Source: Scopus |